Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples